ResearchSafe

Vilon (Vilon (Lys-Glu Dipeptide Immune Bioregulator))

Category: Immune Support. Status: Research compound (peptide bioregulator).

One of the simplest Khavinson peptide bioregulators, a Lys-Glu dipeptide associated with immune and thymic regulation. It is among the most studied short peptides in the Russian bioregulator literature for immune and anti-aging effects.

How it works

As a very short signal peptide (Lys-Glu), it is proposed to bind DNA and modulate gene expression in immune and other tissues, influencing chromatin activity, cytokine balance, and cellular aging markers.

Key facts

  • Molecular weight: ~275 Da
  • Half-life: Short (peptide)
  • Bioavailability: Oral (encapsulated) or subcutaneous
  • Storage: Room temperature (capsules) or refrigerate (injectable).

Dosing overview

  • Typical dose: ~1-2 capsules/day or short injectable courses
  • Frequency: Once daily
  • Duration: 10-30 day courses
  • Route: Oral capsule or subcutaneous

Protocol notes

  • Taken as short repeatable courses (often 10-30 days), a few times per year.
  • Oral encapsulated forms are taken once daily on an empty stomach.
  • Often cycled with Epithalon in bioregulator longevity systems.

Reported benefits

  • Immune regulation support
  • Gene-expression modulation (proposed)
  • Anti-aging tissue effects (proposed)
  • Short course-based protocol

Possible side effects

  • Limited Western clinical data
  • Injection site reactions (injectable)
  • Unknown long-term effects

Research

  • Vilon gene-expression effects (2004): Reported to bind DNA and influence gene expression and immune markers in cell and animal studies.

Compare Vilon

Research and educational reference only. Not medical advice.